Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Development
2009 Jul 01;13613:2277-86. doi: 10.1242/dev.032227.
Show Gene links
Show Anatomy links
MBD4 and MLH1 are required for apoptotic induction in xDNMT1-depleted embryos.
Ruzov A
,
Shorning B
,
Mortusewicz O
,
Dunican DS
,
Leonhardt H
,
Meehan RR
.
???displayArticle.abstract???
Loss of the of the maintenance methyltransferase xDNMT1 during Xenopus development results in premature transcription and activation of a p53-dependent apoptotic program that accounts for embryo lethality. Here, we show that activation of the apoptotic response is signalled through the methyl-CpG binding protein xMBD4 and the mismatch repair pathway protein xMLH1. Depletion of xMBD4 or xMLH1 increases the survival rate of xDNMT1-depleted embryos, whereas overexpression of these proteins in embryos induces programmed cell death at the onset of gastrulation. MBD4 interacts directly with both DNMT1 and MLH1, leading to recruitment of the latter to heterochromatic sites that are coincident with DNMT1 localisation. Time-lapse microscopy of micro-irradiated mammalian cells shows that MLH1/MBD4 (like DNMT1) can accumulate at DNA damage sites. We propose that xMBD4/xMLH1 participates in a novel G2 checkpoint that is responsive to xDNMT1p levels in developing embryos and cells.
Agoston,
Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer.
2005, Pubmed
Agoston,
Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer.
2005,
Pubmed
Bartek,
Chk1 and Chk2 kinases in checkpoint control and cancer.
2003,
Pubmed
Bartkova,
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
2005,
Pubmed
Bellacosa,
Functional interactions and signaling properties of mammalian DNA mismatch repair proteins.
2001,
Pubmed
Bellacosa,
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1.
1999,
Pubmed
Biniszkiewicz,
Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality.
2002,
Pubmed
Bodmer,
Cancer genetics: colorectal cancer as a model.
2006,
Pubmed
Brown,
DNMT1 knockout delivers a strong blow to genome stability and cell viability.
2007,
Pubmed
Brown,
The mismatch repair system is required for S-phase checkpoint activation.
2003,
Pubmed
Canman,
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.
1998,
Pubmed
Cazalla,
A rapid and efficient protocol to purify biologically active recombinant proteins from mammalian cells.
2005,
Pubmed
Chen,
Proteolysis of the mismatch repair protein MLH1 by caspase-3 promotes DNA damage-induced apoptosis.
2004,
Pubmed
Chen,
Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells.
2007,
Pubmed
Cordenonsi,
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.
2003,
Pubmed
,
Xenbase
Cortellino,
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
2003,
Pubmed
De Marzo,
Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.
1999,
Pubmed
Dunican,
xDnmt1 regulates transcriptional silencing in pre-MBT Xenopus embryos independently of its catalytic function.
2008,
Pubmed
,
Xenbase
Easwaran,
Replication-independent chromatin loading of Dnmt1 during G2 and M phases.
2004,
Pubmed
Gius,
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach.
2004,
Pubmed
Goll,
Eukaryotic cytosine methyltransferases.
2005,
Pubmed
Guo,
Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells.
2004,
Pubmed
Halazonetis,
An oncogene-induced DNA damage model for cancer development.
2008,
Pubmed
Hendrich,
The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites.
1999,
Pubmed
Hendrich,
Identification and characterization of a family of mammalian methyl-CpG binding proteins.
1998,
Pubmed
Hensey,
A developmental timer that regulates apoptosis at the onset of gastrulation.
1997,
Pubmed
,
Xenbase
Hershko,
Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse development.
2003,
Pubmed
Jackson-Grusby,
Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation.
2001,
Pubmed
Jair,
De novo CpG island methylation in human cancer cells.
2006,
Pubmed
Jeffery,
Components of the DNA methylation system of chromatin control are RNA-binding proteins.
2004,
Pubmed
Kimura,
Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.
2003,
Pubmed
Klose,
Genomic DNA methylation: the mark and its mediators.
2006,
Pubmed
Kondo,
The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16(INK4a) and hMLH1 genes.
2005,
Pubmed
Lande-Diner,
Role of DNA methylation in stable gene repression.
2007,
Pubmed
Lei,
De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells.
1996,
Pubmed
Leonhardt,
A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei.
1992,
Pubmed
Levine,
The P53 pathway: what questions remain to be explored?
2006,
Pubmed
Li,
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.
1992,
Pubmed
Luo,
ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage.
2004,
Pubmed
Meehan,
Epigenetic silencing in embryogenesis.
2005,
Pubmed
Meehan,
DNA methylation and control of gene expression in vertebrate development.
2001,
Pubmed
,
Xenbase
Miquel,
Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability.
2007,
Pubmed
Morgan,
Epigenetic reprogramming in mammals.
2005,
Pubmed
Mortusewicz,
Recruitment of DNA methyltransferase I to DNA repair sites.
2005,
Pubmed
Mortusewicz,
Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells.
2007,
Pubmed
Palii,
DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
2008,
Pubmed
Papadopoulos,
Mutation of a mutL homolog in hereditary colon cancer.
1994,
Pubmed
Parsons,
MED1: a central molecule for maintenance of genome integrity and response to DNA damage.
2003,
Pubmed
Rai,
DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45.
2008,
Pubmed
Ruzov,
Kaiso is a genome-wide repressor of transcription that is essential for amphibian development.
2004,
Pubmed
,
Xenbase
Saito,
Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas.
2003,
Pubmed
Sansom,
MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine.
2003,
Pubmed
Schroering,
The cell cycle and DNA mismatch repair.
2007,
Pubmed
Shiloh,
ATM and related protein kinases: safeguarding genome integrity.
2003,
Pubmed
Stancheva,
Transient depletion of xDnmt1 leads to premature gene activation in Xenopus embryos.
2000,
Pubmed
,
Xenbase
Stancheva,
Loss of the maintenance methyltransferase, xDnmt1, induces apoptosis in Xenopus embryos.
2001,
Pubmed
,
Xenbase
Takebayashi,
Major and essential role for the DNA methylation mark in mouse embryogenesis and stable association of DNMT1 with newly replicated regions.
2007,
Pubmed
Takebayashi-Suzuki,
Interplay between the tumor suppressor p53 and TGF beta signaling shapes embryonic body axes in Xenopus.
2003,
Pubmed
,
Xenbase
Vertino,
DNMT1 is a component of a multiprotein DNA replication complex.
2002,
Pubmed
Zhang,
Apoptosis induced by overexpression of hMSH2 or hMLH1.
1999,
Pubmed
